News | April 01, 2013

Under the terms of the five-year agreement, IRE will provide an increasing supply of Mo-99

April 1, 2013  Lantheus Medical Imaging Inc. announced a new supply contract with the Belgium-based Institute for Radioelements (IRE) to receive a supply of molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m), for use in its TechneLite (Technetium Tc 99m Generator) generators.

Under the terms of the five-year agreement, IRE will provide an increasing supply of Mo-99 through Dec. 31, 2017. The new agreement also provides for the transition to Mo-99 sourced from Low-Enriched Uranium (LEU) upon IRE’s completion of its ongoing conversion program to modify its facilities and processes in accordance with Belgian nuclear security commitments.

“We are focused on enhancing our balanced and diverse supply chain for this important medical isotope to ensure that we consistently meet the needs of customers and their patients,” said Jeff Bailey, president and CEO of Lantheus Medical Imaging. “Over the course of this agreement, IRE will also help support our strategic initiatives related to supply chain stability and the conversion to 100 percent LEU-derived Mo-99.”

Lantheus has developed a globally diversified and balanced Mo-99 supply chain for the procurement of Mo-99. The company receives Mo-99 from four of the five major processors and seven of the eight associated reactors. 

For more information: www.lantheus.com

Related Content

Videos | Radiopharmaceuticals and Tracers

Ana Kiess, M.D., Ph.D., assistant professor of radiation oncology and molecular radiation sciences, Johns Hopkins ...

Time November 17, 2021
arrow
News | Radiopharmaceuticals and Tracers

September 17, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time September 17, 2021
arrow
News | Radiopharmaceuticals and Tracers

September 10, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time September 10, 2021
arrow
News | Nuclear Imaging

June 22, 2021 — At the Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) 2021 summer conference, GE Healthcare ...

Time June 22, 2021
arrow
News | Radiopharmaceuticals and Tracers

June 22, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time June 22, 2021
arrow
News | Radiopharmaceuticals and Tracers

April 16, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time April 16, 2021
arrow
News | Radiopharmaceuticals and Tracers

March 26, 2021 — Shine Medical Technologies LLC announced that construction of the exterior structure of its first-of-a ...

Time March 26, 2021
arrow
News | Nuclear Imaging

March 8, 2021 — IBA (Ion Beam Applications S.A., EURONEXT) and NorthStar Medical Radioisotopes, LLC, announced a ...

Time March 08, 2021
arrow
News | PET Imaging

January 29, 2021 — Fuzionaire Radioisotope Technologies K.K. (“FRIT”) announced that it has entered into a feasibility ...

Time January 29, 2021
arrow
News | Radiopharmaceuticals and Tracers

February 18, 2020 — NorthStar Medical Radioisotopes, LLC, a global innovator in the production and distribution of ...

Time February 18, 2020
arrow
Subscribe Now